Stockreport

Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients With Depression [Yahoo! Finance]

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF phase trials, announced the first dosing in a Phase II multicenter trial of SPN-820 in adults with major depressive disorder (MDD). DVCR is acting as the full-service CR [Read more]